Home › Academic Library › REG-08
[REG-08] Schedule M (Revised 2023 WHO-GMP Alignment), Quality Management Systems (QMS), IPQC & Pharmaceutical Validation
REG-08 • 12. Pharmaceutical Jurisprudence & Indian Pharmacy LawLearning Objectives
Detail the December 2023 Revised Schedule M notification aligning Indian GMP with WHO-GMP and ICH Q10 Pharmaceutical Quality System (PQS).; Differentiate Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) plus Prospective vs Concurrent Process Validation.; Apply CAPA (Corrective and Preventive Action), Out-of-Specification (OOS), Change Control, and ALCOA+ Data Integrity principles.
Chapter Overview & Core Explanation
Good Manufacturing Practice (Schedule M) ensures that quality is built into every pharmaceutical batch from raw material receipt to finished pack—through validated equipment, environmental monitoring, electronic data integrity, and systematic root-cause investigation.
Key Exam & Clinical Takeaways
- Under Schedule M, reference/retention samples of every finished batch must be preserved for at least 1 year after the expiry date in sufficient quantity to perform at least two full pharmacopoeial analyses.
- Qualification follows the strict sequence DQ → IQ → OQ → PQ before routine commercial Process Validation (3 consecutive commercial batches).